Zentalis Pharmaceuticals Inc. (ZNTL)
ZNTL trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.40
-4.76% on the day
Market cap
$227.2M
Micro cap
Revenue · 2025
$0
-100.0% on 2024
Net income · 2025
-$137.1M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ZNTL on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001725160 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DELAWARE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | -$137.1M |
| Operating income | -$152.8M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | -100.0% |
| Cash | $36.0M |
| Total assets | $289.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-08-14 |
| Latest annual report | 10-K | 2026-03-26 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-08-14 |
| Latest proxy | DEFA14A | 2026-05-27 |
Source: SEC EDGAR submissions feed, 545 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| GLSI | Greenwich LifeSciences Inc. | $15.50 | -12.77% | $227.5M |
| IFRX | InflaRx N.V. | $1.55 | -2.52% | $228.4M |
| NATR | Nature's Sunshine Products Inc. | $12.76 | +0.39% | $224.5M |
| LRMR | Larimar Therapeutics Inc. | $2.16 | -14.63% | $224.4M |
| IMRX | Immuneering Corporation | $3.56 | -7.77% | $230.3M |
| SLGL | Sol-Gel Technologies Ltd. | $68.30 | -5.66% | $223.6M |
| KROS | Keros Therapeutics Inc. | $11.23 | -3.27% | $222.7M |
| SIGA | SIGA Technologies Inc. | $3.08 | -2.53% | $221.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier